MetaCap

Fulgent Genetics (FLGT) vs Freenome (FRNM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Freenome (FRNM) has outperformed Fulgent Genetics (FLGT) over the past year, losing 12.9% versus a loss of 19.6%. Freenome is the larger company by market cap ($1.04 billion vs $673.9 million), about 1.5 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

FLGT-19.60%FRNM-12.93%
+65%+3%-60%
Nov 21, 20251 yearNov 20, 2026
FLGT+26.35%FRNM-7.05%
+75%+22%-31%
Jun 10, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

FLGT versus FRNM key metrics
MetricFLGTFRNM
Share price$24.12$9.36
Market cap$673.89M$1.04B
1-day change-2.66%-5.69%
YTD return-8.18%-28.17%
1-year return-19.60%-12.93%
5-year return-75.28%—
EPS (TTM)$-3.10$-1.28
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$322.67M—
Revenue growth (YoY)+13.83%—
Net income (latest FY)$-60.51M$837.47K
Gross margin40.56%—
Operating margin-28.23%—
Net margin-18.75%—
52-week high$31.04$17.50
52-week low$13.46$9.28
Distance from 52-week high-22.29%-46.51%
Analyst consensusholdstrong_buy
Avg. price target upside+3.65%+92.31%
Average volume330.28K833.65K
Shares outstanding27.94M111.50M
Employees1,315363
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Fulgent Genetics

FLGT stock →

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.

Health Care · Medical Specialities · 1,315 employees

About Freenome

FRNM stock →

Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer.

Health Care · Medical Specialities · 363 employees

FLGT vs FRNM FAQ

Which is bigger, Fulgent Genetics or Freenome?

Freenome (FRNM) is larger, with a market capitalization of $1.04B compared with $673.89M for Fulgent Genetics (FLGT).

Which stock has performed better over the past year, FLGT or FRNM?

FRNM returned -12.93% over the past 12 months, compared with -19.60% for FLGT (price return, excluding dividends). Past performance does not predict future results.

Are Fulgent Genetics and Freenome in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons